Skip to main content

Table 1 Socio-demographic characteristics of the study population (n = 311)

From: Prevalence and determinants of selected cardio-metabolic risk factors among people living with HIV/AIDS and receiving care in the South West Regional Hospitals of Cameroon: a cross-sectional study

Characteristic Total (n = 311) Females (n = 261) Males (n = 50) P*
Age in years, mean (± SD) 43.4 (± 10.6) 41.7 (± 10.6) 45.9 (± 10.4) 0.010
Age, years     0.220
 ≤ 45 197 (63.3%) 169 (85.8%) 28 (14.2%)  
 > 45 114 (36.7%) 92 (80.7%) 22 (19.3%)  
BMI, mean (kg/m2) 25.0 (± 4.7) 25.2 (± 4.8) 23.8 (± 3.7) 0.047
BMI categories (kg/m2)     0.580a
 < 25 182 (58.5%) 158 (82.4%) 32 (17.6%)  
 ≥ 25 to < 30 84 (27%) 70 (83.3%) 14 (16.7%)  
 ≥ 30 45 (14.5%) 41 (91.1%) 4 (8.9%)  
HAART combinations (n = 302)     0.128
 AZT + 3TC + EFV 10 (3.3%) 7 (70%) 3 (30%)  
 AZT + 3TC + NVP 189 (62.6%) 164 (86.8%) 25 (13.2%)  
 AZT + 3TC + NVP + TFV 1 (0.3%) 1 (100%) 0 (0%)  
 TFV + 3TC + EFV 71 (23.5%) 54 (76.1%) 17 (23.9%)  
 TFV + 3TC + LPV + IDV 1 (0.3%) 1 (100%) 0 (0%)  
 TFV + 3TC + NVP 28 (9.3%) 25 (89.3%) 3 (10.7%)  
 D4T + 3TC + NVP 2 (0.7%) 1 (50%) 1 (50%)  
CD4 count, mean (cell/mm3) 470.5 (± 260) 484.4 (± 266.8) 398 (± 208.5) 0.032
CD4 count, cell/mm3     0.060
 CD4 count ≤ 350 95 (30.5%) 74 (77.9%) 21 (22.1%)  
 CD4 count > 350 216 (69.5%) 187 (86.6%) 29 (13.4%)  
  1. AZT zidovudine, 3TC lamivudine, EFV efavirenze, TDF tenofovir, IDV indinavir, D4T stavudine, LPV lopinavir, BMI body mass index, SD standard deviation
  2. * P value for comparison between males and females; data are presented as mean ± SD or counts (%)
  3. aP value after fisher’s exact test